Patent SG-11201805192Q-A (SG)
Title: Respiratory syncytial virus vaccine
Inventor: YAN HUIMIN
IPC: C07K19/00
Filed: 2016-10-31
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 111111111111111111111111111111111111111111111111111111111111111111111111111111 Organization International Bureau (10) International Publication Number (43) International Publication Date ......0\" WO 2018/076342 Al 03 May 2018 (03.05.2018) WIP0 I PCT (51) (21) (22) (25) Filing Language: (26) (71) Applicant: WUHAN SANLI BIOTECHNOLOGY CO., (72) Inventors: YAN, Huimin; Xiaohongshan 44#, Wuchang International Patent Classification: (84) Designated States (unless otherwise indicated, for every A61K 39/155 (2006.01) A61P 31/14 (2006.01) kind of regional protection available): ARIPO (BW, GH, C07K 19/00 (2006.01) A61P 11/00 (2006.01) GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, International Application Number: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, PCT/CN2016/104026 TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, International Filing Date: MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, 31 October 2016 (31.10.2016) TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). English Publication Language: English Published: — with international search report (Art. 21(3)) — with sequence listing part of description (Rule 5.2(a)) LTD. [CN/CN]; Happiness 4th Road, Miaoshan Develop- ment Zone, Jiangxia, Wuhan, Hubei 430223 (CN). District, Wuhan, Hubei 430071 (CN). YANG, Jingyi; Xi- aohongshan 44#, Wuchang District, Wuhan, Hubei 430071 (CN). ZHAO, Bali; Xiaohongshan 44#, Wuchang District, Wuhan, Hubei 430071 (CN). Agent: SCIHEAD IP LAW FIRM; Room 1508, Huihua Commercial & Trade Building, No. 80, Xianliezhong Road, Yuexiu, Guangzhou, Guangdong 510070 (CN). Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (74) (81) = = — = = = = = = = Title: RESPIRATORY SYNCYTIAL : A respiratory syncytial fusion protein antigen identity to the polypeptide represented a polypeptide that shares at least are covalently coupled so as to form a linear polypeptide. (54) 60 recombinant moiety VIRUS VACCINE 10 1 30 20 50 r j—rj flagellin moiety is a polypeptide that shares at least NO 40 protein antigen. In one embodiment, the moiety, wherein the flagellin moiety 8; whereby the P moiety and flagellin = = = = Il ei 71- en IN © (57) Il 90% © is ei 2 fusion P ID FIG 2 (a) virus (RSV) vaccine comprising a recombinant comprises a phosphoprotein by SEQ ID NO or SEQ ID NO 4; and a 90% identity to the polypeptide (P) moiety, wherein the represented by SEQ